Hybrid eventIn-person & virtual
March 15–17, 2027Singapore · Village Hotel Changi
Session Track · CIOC 2027

Esthesioneuroblastoma at CIOC 2027

Part of the CIOC 2027 scientific programme · Village Hotel Changi, Singapore · March 15–17, 2027

About the Esthesioneuroblastoma Session

Esthesioneuroblastoma, a rare type of cancer, arises from the olfactory epithelium in the nasal cavity. Research on esthesioneuroblastoma focuses on understanding its genetic and molecular characteristics to develop targeted therapies. Scientists are exploring novel treatment approaches such as immunotherapy and precision medicine to improve patient outcomes. Additionally, advancements in imaging techniques aid in early detection and accurate staging of the disease, enabling timely intervention. Collaborative efforts among oncologists, geneticists, and bioinformaticians are essential to unravel the complexities of esthesioneuroblastoma and devise personalized treatment strategies. Despite its rarity, ongoing research endeavors strive to enhance our understanding of this malignancy and pave the way for more effective therapies, offering hope to individuals affected by esthesioneuroblastoma.

Topics Covered in Esthesioneuroblastoma

Topic 01

Olfactory Epithelium Origin

Topic 02

Histologic Grading

Topic 03

Neuroendocrine Markers

Topic 04

Endoscopic Resection

Topic 05

Adjuvant Radiotherapy

Topic 06

Neck Node Management

Related Scientific Sessions at CIOC 2027

Why Attend the Esthesioneuroblastoma Conference 2027

Earn CPD Credit

Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.

Present Your Research

Oral and poster slots for original Esthesioneuroblastoma work, reviewed by the scientific committee.

Network Globally

Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.

Publish & Get Indexed

Accepted abstracts appear in the indexed conference proceedings with a citable DOI.

Learn from Keynotes

Plenary lectures from leading voices shaping Esthesioneuroblastoma research and practice.

Hybrid Flexibility

Attend in person in Singapore or join virtually — same programme, same certificate.

Join CIOC 2027 for the Esthesioneuroblastoma track

Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.

Esthesioneuroblastoma Conference 2027 — FAQs

What is the Esthesioneuroblastoma track at CIOC 2027?

The Esthesioneuroblastoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Esthesioneuroblastoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.

Who should attend the Esthesioneuroblastoma sessions?

Cancer researchers and clinicians, educators and students with an interest in Esthesioneuroblastoma are all welcome — whether presenting or attending.

Can I present my research in the Esthesioneuroblastoma track?

Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.

Is virtual attendance available for Esthesioneuroblastoma sessions?

Yes. CIOC 2027 is a hybrid conference — attend the Esthesioneuroblastoma track in person in Singapore or join live online, with on-demand access afterward.

Join the CIOC 2027 delegation

Singapore · March 15–17, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us